Caspase-mediated cleavage of proteins ensures the irreversible commitment of cells to undergo apoptosis, and is thus a hallmark of apoptosis. Rapamycin-insensitive companion of mTOR (rictor) functions primarily as a core and essential component of mTOR complex 2 (mTORC2) to critically regulate cellular homeostasis. However, its role in the regulation of apoptosis is largely unknown. In the current study, we found that rictor was cleaved to generate two small fragments at ~ 50 kD and ~ 130 kD in cells undergoing apoptosis upon treatment with different stimuli such as the death ligand, TRAIL, and the small molecule, AZD9291. This cleavage was abolished when caspases were inhibited and could be reproduced when directly incubating rictor protein and caspase-3 in vitro. Furthermore, the cleavage site of caspase-3 on rictor was mapped at D1244 (VGVD). These findings together robustly demonstrate that rictor is a substrate of caspase-3 and undergoes cleavage during apoptosis. These results add new information for understanding the biology of rictor in the regulation of cell survival and growth.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
All data have been included in this manuscript and materials are available upon request.
Fulda S (2009) Apoptosis pathways and their therapeutic exploitation in pancreatic cancer. J Cell Mol Med 13:1221–1227
Hengartner MO (2000) The biochemistry of apoptosis. Nature 407:770–776
Fischer U, Janicke RU, Schulze-Osthoff K (2003) Many cuts to ruin: a comprehensive update of caspase substrates. Cell Death Differ 10:76–100
Sarbassov DD, Ali SM, Kim DH et al (2004) Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr Biol 14(14):1296–1302
Oh WJ, Jacinto E (2011) mTOR complex 2 signaling and functions. Cell Cycle 10:2305–2316
Su B, Jacinto E (2011) Mammalian TOR signaling to the AGC kinases. Crit Rev Biochem Mol Biol 46:527–547
Hresko RC, Mueckler M (2005) mTOR.RICTOR is the Ser473 kinase for Akt/protein kinase B in 3T3-L1 adipocytes. J Biol Chem 280:40406–40416
Sarbassov DD, Guertin DA, Ali SM, Sabatini DM (2005) Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307:1098–1101
Driscoll DR, Karim SA, Sano M et al (2016) mTORC2 signaling drives the development and progression of pancreatic cancer. Cancer Res 76:6911–6923
Guertin DA, Stevens DM, Saitoh M et al (2009) mTOR complex 2 is required for the development of prostate cancer induced by Pten loss in mice. Cancer Cell 15:148–159
Lee K, Nam KT, Cho SH et al (2012) Vital roles of mTOR complex 2 in Notch-driven thymocyte differentiation and leukemia. J Exp Med 209:713–728
Masri J, Bernath A, Martin J et al (2007) mTORC2 activity is elevated in gliomas and promotes growth and cell motility via overexpression of rictor. Cancer Res 67:11712–11720
Roulin D, Cerantola Y, Dormond-Meuwly A, Demartines N, Dormond O (2010) Targeting mTORC2 inhibits colon cancer cell proliferation in vitro and tumor formation in vivo. Mol Cancer 9:57
Zheng NN, Ding XD, Zhang HP (2013) Targeting rictor inhibits mouse vascular tumor cell proliferation and invasion in vitro and tumor growth in vivo. Neoplasma 60:41–45
Sparks CA, Guertin DA (2010) Targeting mTOR: prospects for mTOR complex 2 inhibitors in cancer therapy. Oncogene 29:3733–3744
Gao D, Wan L, Inuzuka H et al (2010) Rictor forms a complex with Cullin-1 to promote SGK1 ubiquitination and destruction. Mol Cell 39:797–808
Guo Z, Zhou Y, Evers BM, Wang Q (2012) Rictor regulates FBXW7-dependent c-Myc and cyclin E degradation in colorectal cancer cells. Biochem Biophys Res Commun 418:426–432
Koo J, Wu X, Mao Z, Khuri FR, Sun SY (2015) Rictor undergoes GSK3-dependent, FBXW7-mediated ubiquitination and proteasomal degradation. J Biol Chem 290(22):14120–14129
Serrano I, McDonald PC, Lock FE, Dedhar S (2013) Role of the integrin-linked kinase (ILK)/Rictor complex in TGFbeta-1-induced epithelial-mesenchymal transition (EMT). Oncogene 32:50–60
Agarwal NK, Chen CH, Cho H, Boulbes DR, Spooner E, Sarbassov DD (2013) Rictor regulates cell migration by suppressing RhoGDI2. Oncogene 32:2521–2526
Hagan GN, Lin Y, Magnuson MA, Avruch J, Czech MP (2008) A Rictor-Myo1c complex participates in dynamic cortical actin events in 3T3-L1 adipocytes. Mol Cell Biol 28:4215–4226
Koo J, Yue P, Deng X, Khuri FR, Sun SY (2015) mTOR complex 2 stabilizes Mcl-1 protein by suppressing its GSK3-dependent and SCF-FBXW7-mediated degradation. Mol Cell Biol 35:2344–2355
Zhao L, Yue P, Khuri FR, Sun SY (2013) mTOR complex 2 is involved in regulation of Cbl-dependent c-FLIP degradation and sensitivity of TRAIL-induced apoptosis. Cancer Res 73:1946–1957
Li Y, Zang H, Qian G, Owonikoko TK, Ramalingam SR, Sun SY (2019) ERK inhibition effectively overcomes acquired resistance of epidermal growth factor receptor-mutant non-small-cell lung cancer cells to osimertinib. Cancer 126(6):1339–1350
Qian G, Yao W, Zhang S et al (2018) Co-inhibition of BET and proteasome enhances ER stress and Bim-dependent apoptosis with augmented cancer therapeutic efficacy. Cancer Lett 435:44–54
Shi P, Oh YT, Deng L et al (2017) Overcoming acquired resistance to AZD9291, a third-generation EGFR inhibitor, through modulation of MEK/ERK-dependent Bim and Mcl-1 degradation. Clin Cancer Res 23:6567–6579
Sun SY, Yue P, Mao L et al (2000) Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells. Clin Cancer Res 6:1563–1573
Zhang S, Qian G, Shi P et al (2021) Downregulation of death receptor 4 is tightly associated with positive response of EGFR mutant lung cancer to EGFR-targeted therapy and improved prognosis. Theranostics 11:3964–3980
Sun SY, Yue P, Wu GS et al (1999) Mechanisms of apoptosis induced by the synthetic retinoid CD437 in human non-small cell lung carcinoma cells. Oncogene 18:2357–2365
Sun SY, Yue P, Zhou JY et al (2001) Overexpression of BCL2 blocks TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in human lung cancer cells. Biochem Biophys Res Commun 280:788–797
Ruegg UT, Burgess GM (1989) Staurosporine, K-252 and UCN-01: potent but nonspecific inhibitors of protein kinases. Trends Pharmacol Sci 10:218–220
Manns J, Daubrawa M, Driessen S et al (2011) Triggering of a novel intrinsic apoptosis pathway by the kinase inhibitor staurosporine: activation of caspase-9 in the absence of Apaf-1. FASEB J 25:3250–3261
El Shamieh S, Saleh F, Moussa S, Kattan J, Farhat F (2018) RICTOR gene amplification is correlated with metastasis and therapeutic resistance in triple-negative breast cancer. Pharmacogenomics 19:757–760
Cheng H, Zou Y, Ross JS et al (2015) RICTOR amplification defines a novel subset of patients with lung cancer who may benefit from treatment with mTORC1/2 inhibitors. Cancer Discov 5:1262–1270
Zhao D, Jiang M, Zhang X, Hou H (2020) The role of RICTOR amplification in targeted therapy and drug resistance. Mol Med 26:20
Wong CK, Lambert AW, Ozturk S et al (2020) Targeting RICTOR sensitizes SMAD4-negative colon cancer to irinotecan. Mol Cancer Res (MCR) 18:414–423
Im-aram A, Farrand L, Bae SM et al (2013) The mTORC2 component rictor contributes to cisplatin resistance in human ovarian cancer cells. PLoS ONE 8:e75455
Morrison Joly M, Hicks DJ, Jones B et al (2016) Rictor/mTORC2 Drives progression and therapeutic resistance of HER2-Amplified breast cancers. Cancer Res 76:4752–4764
We are thankful to Drs. Chunhai Hao and Keqiang Ye for sharing some cell lines and grateful to Dr. Anthea Hammond in our department for editing the manuscript. SY Sun is a Georgia Research Alliance Distinguished Cancer Scientist.
This study was supported by the Emory Winship Cancer Institute lung cancer research pilot funds (to SYS). S-Y Sun was suported by NIH/NCI R01 CA223220 (to SYS) and R01 CA245386 (to SYS).
Conflict of interest
No potential conflicts of interest were disclosed.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Zhao, L., Zhu, L., Oh, YT. et al. Rictor, an essential component of mTOR complex 2, undergoes caspase-mediated cleavage during apoptosis induced by multiple stimuli. Apoptosis 26, 338–347 (2021). https://doi.org/10.1007/s10495-021-01676-y